News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Exyn Technologies and Stitch3D Announce Partnership; Exyn Advances AI Aerial Autonomy Technology to Overcome Dust in Underground Mines
The goal of the collaboration is to to host, manage, view, process and share point cloud data securely directly on the web.
iECURE included on list of Fierce Biotech’s 2024 Fierce 15
iECURE was recognized for its innovative approach to treating rare childhood diseases by developing therapies that correct gene function directly inside the body.
Penn Spinout Interius BioTherapeutics Raises Additional $67M and doses first patient
The company’s approach focuses on creating cancer-fighting cells directly inside the body, potentially bypassing the need for external cell manipulation and chemotherapy.
Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases
Carisma has expanded its collaboration with Moderna to develop two chimeric antigen receptor macrophage (CAR-M) targets for autoimmune disease treatment.
Tern Therapeutics Launches with $15 Million in Financing and CLN2 Batten Disease Treatment Pipeline from REGENXBIO
Tern Therapeutics, a biotechnology company focused on developing gene therapies for rare diseases, recently launched with $15 million in financing.
Dr. James Wilson takes on roles in two new companies spun out of Penn’s Gene Therapy Program
James Wilson, MD, PhD, has left Penn after 33 years to take on leadership roles in two independent startups that he co-founded.
Penn Medicine and Parker Institute renew alliance to continue advancing groundbreaking cancer immunotherapy research
Penn Medicine and the Parker Institute for Cancer Immunotherapy (PICI) have renewed their collaboration to advance cancer immunotherapy research at Penn Medicine’s Abramson Cancer Center (ACC).
Fast Company and Inc Rank Penn as Second on The Ignition Schools List
The list ranks “top academic institutions that play an enormous role in shaping the businesses that influence society”.
PCI Mourns the Loss of Eric Corkhill, former Chairman and CEO of Neuralert Technologies
he Penn Center for Innovation is deeply saddened by the passing of Eric Corkhill, who served as Chairman and CEO of Neuralert Technologies.
Press Highlights of FY24
During the 2022 fiscal year, there were 98 press mentions for PCI programs, startups and partners. Some of the most popular and widely circulated stories are included here.